Home › Books › Violations Of 21 CFR Part 312 - Investigational New Drug Ap…
Violations Of 21 CFR Part 312 - Investigational New Drug Application: Warning Letters Issued by U.S. Food and Drug Administration (FDA Warning Letters Analysis) (Volume 4) Buy on Amazon

https://www.ebooknetworking.net/books_detail-1514626632.html

Violations Of 21 CFR Part 312 - Investigational New Drug Application: Warning Letters Issued by U.S. Food and Drug Administration (FDA Warning Letters Analysis) (Volume 4)

AuthorC Chang
PublisherCreateSpace Independent Publishing Platform
Shop on Amazon — choose your country
🇺🇸 USA 🇨🇦 Canada 🇬🇧 UK 🇩🇪 Germany 🇫🇷 France 🇮🇳 India
129.00 USD
Buy New on Amazon 🇺🇸

Book Details

Author(s)C Chang
PublisherCreateSpace Independent Publishing Platform
ISBN / ASIN1514626632
ISBN-139781514626634
MarketplaceUnited States  🇺🇸

More Books by C Chang

Violations Of 21 CFR Part 58 - Good Laboratory Practice for Nonclinical Laboratory: Warning Letters Issued by U.S. Food and Drug Administration (FDA Warning Letters Analysis) (Volume 3)
Violations Of 21 CFR Part 58 - Good Laboratory Practic…
View
Violations Of 21 CFR Part 803 - Medical Device Reporting: Warning Letters Issued by U.S. Food and Drug Administration (FDA Warning Letters Analysis) (Volume 5)
Violations Of 21 CFR Part 803 - Medical Device Reporti…
View
Violations Of 21 CFR Part 820 - Quality System Regulation, Subpart M Records: Warning Letters Issued by U.S. Food and Drug Administration (FDA Warning Letters Analysis) (Volume 15)
Violations Of 21 CFR Part 820 - Quality System Regulat…
View
Violations Of 21 CFR Part 820 Quality System Regulation: Subpart K- Labeling and Packaging Control, Subpart L- Handling, Storage, Distribution, and ... (FDA Warning Letters Analysis) (Volume 14)
Violations Of 21 CFR Part 820 Quality System Regulatio…
View
Donate to EbookNetworking
Prev
Next